Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.2 Primary Research
2.1.3 Key Data From Primary Sources
2.1.4 Key Insights From Primary Sources
2.1.4.1 Key Industry Insights
2.1.5 Market Size Estimation Methodology
2.1.6 Research Design
2.1.7 Market Data Validation and Triangulation
2.1.8 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Market Overview of Neuromodulation
4.2 Global Neuromodulation Market, By Type
4.3 Geographic Analysis of the Deep Brain Stimulation Market, By Application
4.4 Internal Neuromodulation Market, By Modality
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Segmentation of Neuromodulation
5.3 Market Dynamics of Neuromodulation
5.1 Drivers
5.1.1.1 Rising Prevalence of Neurological Disorders to Spur Market Growth
5.1.1.2 Unprecedented Increase in the Aging Population to Fuel Market Growth
5.1.1.3 Strong Product Pipeline to Propel the Market
5.1.1.4 Expanded Target Applications and New Indications are Expected to Stimulate the Growth of Neuromodulation Devices
5.1.1.5 Investments and Funds – an Impetus for Market Growth
5.2 Restraints
5.2.1.1 Unfavorable Reimbursement Scenario Hinders Market Growth
5.2.1.2 Lack of Trained Professionals Likely to Hamper Market Growth
5.3 Opportunities
5.3.1.1 Expansion in Emerging Economies

6 Global Neuromodulation Market, By Technology
6.1 Introduction
6.2 Internal Neuromodulation
6.2.1 Spinal Cord Stimulation (SCS)
6.2.2 Deep Brain Stimulation (DBS)
6.2.3 Vagus Nerve Stimulation (VNS)
6.2.4 Sacral Nerve Stimulation (SNS)
6.2.5 Gastric Electrical Stimulation (GES)
6.3 External Neuromodulation (Non-Invasive)
6.3.1 Transcutaneous Electrical Nerve Stimulation (Tens)
6.3.2 Transcranial Magnetic Stimulation (TMS)
6.3.3 Respiratory Electrical Stimulation (RES)

7 Global Neuromodulation Market, By Application
7.1 Introduction
7.2 Spinal Cord Stimulation (SCS) Market, By Application
7.2.1 Failed Back Syndrome (FBSS)
7.2.2 Chronic Pain
7.2.3 Ischemia
7.3 Deep Brain Stimulation (DBS) Market, By Application
7.3.1 Parkinson’s Disease
7.3.2 Tremor
7.3.3 Depression
7.3.4 Other Dbs Applications
7.4 Sacral Nerve Stimulation Market, By Application
7.4.1 Urine Incontinence
7.4.2 Fecal Incontinence
7.5 Vagus Nerve Stimulation Market, By Application
7.5.1 Epilepsy
7.5.2 Other Vns Applications
7.6 Gastric Electrical Stimulation Market, By Application
7.6.1 Gastroparesis
7.6.2 Obesity
7.7 Transcutaneous Electrical Nerve Stimulation Market, By Application
7.7.1 Treatment Resistant Depression
7.7.2 Other Tens Applications
7.8 Repetitive Transcranial Magnetic Stimulation Market, By Application
7.8.1 Depression
7.8.2 Migraine Headache
7.9 Respiratory Electrical Stimulation Market, By Application
7.9.1 Spinal Cord Injury

8 Neuromodulation Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Chronic Diseases In The U.S.
8.2.1.2 Increasing Aging Population In The U.S.
8.2.1.3 Increasing Lyme Disease Cases In The U.S.
8.2.1.4 Conferences & Annual Meetings To Increase Exposure of Neuromodulation
8.2.2 Canada
8.2.2.1 Increasing Incidence of Lyme Disease In Canada
8.2.2.2 Increasing Incidences of Cancer And Diabetes
8.2.3 Europe
8.2.3.1.1 Rapidly Aging Population In Europe
8.2.3.1.2 Conferences & Annual Meetings To Increase Exposure To Neuromodulation in the European Market
8.2.3.2 Germany
8.2.3.2.1 Rising Prevalence of Parkinson’s Disease In Germany
8.2.3.3 U.K.
8.2.3.3.1 Rising Prevalence of Diabetes In The U.K.
8.2.3.3.2 Rise In CVD Prevalence In The U.K.
8.2.3.4 France
8.2.3.4.1 Rising Incidences of Alzheimer's Disease And Dementia
8.2.3.5 Rest of Europe
8.2.3.5.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine
8.2.4 Asia-Pacific
8.2.4.1 Japan
8.2.4.1.1 Rising Adoption of Neurostimulation
8.2.4.2 China
8.2.4.2.1 High Diabetes Incidences And Rapidly Aging Population
8.2.4.3 India
8.2.4.3.1 Increasing Geriatric Population & High Diabetes Incidence
8.2.4.3.2 Conferences On Neuromodulation & Pain Management In India
8.2.4.4 Rest of Asia-Pacific (ROAPAC)
8.2.4.4.1 Increasing Prevalence of Parkinson’s Disease In Singapore
8.2.4.4.2 Conferences On Neuromodulation In Australia
8.2.5 Rest of The World
8.2.5.1.1 Increasing Incidences of Cancer In Latin America
8.2.5.1.2 Rise In Aging Population & Prevalence of Diabetes

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis fo Neuromodulation, By Key Player
9.2.1 Introduction
9.3 Medtronic, Inc.
9.4 Boston Scientific Corporation
9.5 ST. Jude Medical, Inc.
9.6 Competitive Scenario
9.6.1 Market Development of Neuromodulation
9.6.2 Agreements, Collaborations, Mergers, and Partnerships
9.6.3 New Product Launches
9.6.4 Acquisitions
9.6.5 Expansion

10 Company Profiles
10.1 Introduction
10.2 Medtronic, Inc.
10.2.1 Business Overview
10.2.2 Medtronic, Inc.: Company Snapshot
10.2.3 Products & Services
10.2.4 Recent Developments
10.2.5 MnM View
10.3 Boston Scientific Corporation
10.3.1 Business Overview
10.3.2 Boston Scientific Corporation: Company Snapshot
10.3.3 Product Offerings
10.3.4 Recent Developments
10.3.5 MnM View
10.4 ST. Jude Medical, Inc.
10.4.1 Business Overview
10.4.2 ST Jude Medical, Inc.: Company Snapshot
10.4.3 Product Offerings:
10.4.4 Recent Developments
10.4.5 MnM View
10.5 Cyberonics, Inc.
10.5.1 Business Overview
10.5.2 Cyberonics, Inc.: Company Snapshot
10.5.3 Product Portfolio
10.5.4 Recent Developments
10.6 Nevro Corporation
10.6.1 Business Overview
10.6.2 Nevro Corporation: Company Snapshot
10.6.3 Product Offerings
10.6.4 Recent Developments
10.7 Neurosigma, Inc.
10.7.1 Business Overview
10.7.2 Neurosigma, Inc.: Company Snapshot
10.7.3 Product Offerings
10.7.4 Recent Developments
10.8 Neuropace, Inc.
10.8.1 Business Overview
10.8.2 Neuropace, Inc.: Company Snapshot
10.8.3 Product Offerings
10.8.4 Recent Developments
10.9 Biocontrol Medical
10.9.1 Business Overview
10.9.2 Biocontrol Medical: Company Snapshot
10.9.3 Product Offerings
10.9.4 Recent Developments
10.10 Synapse Biomedical, Inc.
10.10.1 Business Overview
10.10.2 Synapse Biomedical, Inc.: Company Snapshot
10.10.3 Product Offerings
10.10.4 Recent Developments
10.11 Neuronetics, Inc.
10.12 Business Overview
10.12.1 Neuronetics, Inc.: Company Snapshot
10.12.2 Product and Service Offerings
10.12.3 Recent Developments

11 Appendix
11.1 Discussion Guide
11.2 Company Developments (2012-2015)
11.2.1 Medtronic, Inc.
11.2.2 Boston Scientific Corporation
11.2.3 ST Jude Medical, Inc.
11.2.4 Neurosigma, Inc.
11.3 Introducing RT: Real-Time Market Intelligence
11.4 Available Customizations
11.5 Related Reports

List of Tables

Table 1 Increasing Incidence of Neurological Disorders is Propelling the Growth of the Global Neuromodulation Market
Table 2 Unfavourable Reimbursement Structure is Restraining the Growth of the Global Neuromodulation Market
Table 3 Expansion in Emerging Markets has a Huge Potential for Growth in the Global Neuromodulation Market
Table 4 Global Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 5 Internal Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 6 Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 7 Internal Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 8 Spinal Cord Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 9 Spinal Cord Stimulation Market Size, 2013-2020 (Units)
Table 10 Deep Brain Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 11 Deep Brain Stimulation Market Size, 2013-2020 (Units)
Table 12 Vagus Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 13 Vagus Nerve Stimulation Market Size, 2013-2020 (Units)
Table 14 Sacral Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 15 Sacral Nerve Stimulation Market Size, 2013-2020 (Units)
Table 16 Gastric Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 17 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 18 External Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 19 External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 20 External Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 21 Transcutaneous Electrical Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 22 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 23 Transcranial Magnetic Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 24 Transcranial Magnetic Stimulation Market Size, 2013-2020 (Units)
Table 25 Respiratory Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 26 Respiratory Electrical Stimulation Market Size, 2013-2020 (Units)
Table 27 Global Spinal Cord Stimulation Market, By Application, 2013–2020 ($Million)
Table 28 Global Deep Brain Stimulation Market, By Application, 2013–2020 ($Million)
Table 29 Global Sacral Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 30 Global Vagus Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 31 Global Gastric Electrical Stimulation Market, By Application, 2013–2020 ($Million)
Table 32 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 33 Global Transcranial Magnetic Stimulation Market, By Application, 2013–2020 ($Million)
Table 34 Neuromodulation Market Size, By Region, 2013-2020($Million)
Table 35 North America: Neuromodulation Market Size, By Country, 2013–2020 ($Million)
Table 36 North America: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 37 North America: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 38 North America: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 39 U.S.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 40 U.S.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 41 U.S.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 42 Canada: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 43 Canada: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 44 Canada: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 45 Europe: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 46 Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 47 Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 48 Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 49 Germany: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 50 Germany: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 51 Germany: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 52 U.K.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 53 U.K.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 54 U.K.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 55 France: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 56 France: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 57 France: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 58 Rest of Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 59 Rest of Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 60 Rest of Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 61 Asia-Pacific: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 62 Asia-Pacific: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 63 Asia-Pacific: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 64 Asia-Pacific: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 65 Japan: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 66 Japan: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 67 Japan: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 68 China: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 69 China: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 70 China: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 71 India: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 72 India: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 73 India: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 74 ROAPAC: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 75 ROAPAC: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 76 ROAPAC: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 77 Rest of the World: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 78 Rest of the World: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 79 Rest of the World: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 80 Recent Developments, 2012–2014
Table 81 Recent Developments, 2012–2014
Table 82 Recent Developments, 2012–2014
Table 83 Recent Developments, 2012–2014
Table 84 Recent Developments, 2012–2014

List of Figures

Figure 1 Market Segmentation
Figure 2 Market Research Methodology Steps
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Internal Neuromodulation Segment to Witness the Highest CAGR of11.4% From 2015 to 2020
Figure 8 Deep Brain Stimulation to Grow at the Highest CAGR of 14.2% During the Forecast Period
Figure 9 Transcutaneous Electrical Nerve Stimulation is Expected to Command the Largest Share in 2015
Figure 10 Parkinson’s Disease is Expected to Command the Largest Share in 2015
Figure 11 Asia-Pacific Slated to Witness the Highest Growth in the Neuromodulation Market During the Forecast Period
Figure 12 Attractive Opportunities in the Neuromodulation Market
Figure 13 Internal Modulation Technology to Witness the Highest Growth During the Forecast Period
Figure 14 North America to Dominate the Neuromodulation Market
Figure 15 Deep Brain Stimulation Segment to Witness Highest Growth Rate During the Forecast Period
Figure 16 Asia-Pacific to Witness Highest Growth Rate From 2015 to 2020
Figure 17 Global Neuromodulation Market, By Type
Figure 18 Internal Neuromodulation Segment to Grow at the Highest CAGR of11.2% During the Forecast Period
Figure 19 Asia-Pacific to Grow at the Highest CAGR of 14.9% During the Forecast Period
Figure 20 Asia-Pacific to Grow at the Highest CAGR of 13.4% During the Forecast Period
Figure 21 Transcranial Magnetic Stimulation to Grow at the Highest CAGR During the Forecast Period
Figure 22 Global  Internal Neuromodulation  Market, By Application
Figure 23 Global  External Neuromodulation  Market, By Application
Figure 24 North America is Expected to Command the Largest Share of the Global Market in 2015
Figure 25 U.S. to Witness the Highest Growth in the Global Market in North America (2015)
Figure 26 Germany to Witness the Highest Growth in the Global Neuromodulation Market in Europe (2015)
Figure 27 Asia-Pacific, the Fastest-Growing Segment in the Global Market
Figure 28 RoW Expected to Grow at A CAGR of 13.3% During 2015 to 2020
Figure 29 Market Share Analysis of Neuromodulation, By Key Player, 2014
Figure 30 Neuromodulation Strategies Adopted By Key Players Over the Last Four Years (2012-2015)
Figure 31 Battle for Market Share of Neuromodulation: Market Develpoment was the Key Strategy
Figure 32 Neuromodulation Geographical Revenue Mix of Top Players

• Renewable Energy Sources Needs To Boost Global Microgrids Market
  The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting&hellip
• Manufacturing Trends In The Coming Days
  The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and&hellip
• Top 10 Emerging Technologies
  The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries,&hellip
• Global Biosimilars Market To Be Led By Novartis by 2020
  Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the&hellip
• Global Thyroid Gland Disorder Treatment Market To Grow Steadily
  The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The&hellip
• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

• Improving Standards Of Living To Boost Global Consumer Durables Market

Consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time. Profits in the consumer durables sector were most profoundly…

United States Microbial Identification Market Report 2017

Published: 26-Jul-2017        Price: US 3800 Onwards        Pages: 108

In this report, the United States Microbial Identification market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume) , revenue (value) , market shar......

Global Electrophoresis Sales Market Report 2017

Published: 26-Jul-2017        Price: US 4000 Onwards        Pages: 124

In this report, the global Electrophoresis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Electrophoresis for these regions, from 2012 to 2022 (forecast) , covering - United States - China - Europe - Japa......

Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 45

Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2017 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2017'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 5 molecules. Out of which approximately 2 molecules are developed by c......

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 51

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2017 Summary Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or T......

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 48

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Pipeline Review, H2 2017 Summary Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Alpha-2C adrenergic receptor or ADRA2C is an alpha-2 adrenergic receptor. It mediates the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. This receptor plays a critical role in re......

G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 34

G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Pipeline Review, H2 2017 Summary According to the recently published report 'G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2017'; G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) pipeline Target constitutes close......

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 39

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2017 Summary Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 6 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The latest report Metabotropic Glutamate Receptor 4 - Pipeline Review, H2 2017, outlays comprehensive information on the Metabotropic Glutamate Recepto......

Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 72

Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H2 2017 Summary Smoothened Homolog (Protein Gx or SMO) - Smoothened homolog (SMO) is a G protein-coupled receptor that probably associates with the patched protein (PTCH) to transduce the hedgehog's proteins signal. Binding of sonic hedgehog (SHH) to its receptor is thought to prevent normal inhibition by patched of smoothened (SMO). It is required for the accumulation of KIF7 and GLI3 in the cilia. ......

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H2 2017

Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 39

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H2 2017 Summary According to the recently published report 'P2X Purinoceptor 7 - Pipeline Review, H2 2017'; P2X Purinoceptor 7 (P2Z Receptor or P2RX7) pipeline Target constitutes close to 9 molecules. Out of which approximately 9 molecules are developed by Companies. P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - P2X purinoceptor 7 is a protein encoded by the P2RX7 gene. It acts as receptor fo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs